Avience Biomedicals Ltd vs Sunil Healthcare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Avience Biomedicals Ltd is ₹ 240 as of 23 Oct 15:30 . The P/E Ratio of Avience Biomedicals Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Sunil Healthcare Ltd changed from 11.4 on March 2022 to 15.9 on March 2026 . This represents a CAGR of 6.88% over 5 years The Market Cap of Avience Biomedicals Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Sunil Healthcare Ltd changed from ₹ 23.43 crore on March 2021 to ₹ 63.55 crore on March 2026 . This represents a CAGR of 18.09% over 6 years The revenue of Avience Biomedicals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Sunil Healthcare Ltd for the Jun '26 is ₹ 19.21 crore as compare to the Mar '26 revenue of ₹ 20.13 crore. This represent the decline of -4.57% The ebitda of Avience Biomedicals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Sunil Healthcare Ltd for the Jun '26 is ₹ 3.15 crore as compare to the Mar '26 ebitda of ₹ 2.23 crore. This represent the growth of 41.26% The net profit of Avience Biomedicals Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Sunil Healthcare Ltd changed from ₹ -0.69 crore to ₹ 0.46 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of Avience Biomedicals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Sunil Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Avience Biomedicals Ltd

Avience Biomedicals Limited was originally incorporated as Private Limited Company as 'Avience Biomedicals Private Limited' on December 23, 2019 with the Registrar of Companies, Delhi.
Later, Company's status got converted into a Public Limited Company, the name of the Company was changed to 'Avience Biomedicals Limited' and fresh Certificate of incorporation dated September 3, 2024, was issued by the Registrar of Companies, Delhi. Avience Biomedicals Limited is a medical consumable company dedicated to manufacturing of Vitro-Diagnostic (IVD) products and medical devices in Noida, Uttar Pradesh, India.
In vitro diagnostics (IVDs) are tests that can detect disease, conditions and infections. The Company commenced its journey by producing essential diagnostic kits like Viral Transport Media (VTM), Covid, Human Immunodeficiency Viruses (HIV), HBs AG, Malaria, Dengue and others aimed at aiding medical institutions with affordable and good-quality solutions.

About Sunil Healthcare Ltd

Sunil Healthcare Limited (Formerly known Sunil Synchem Ltd) was incorporated in 1973.
The Company introduced plant at Alwar; Rajasthan for manufacture of Empty Hard Gelatin Capsule Shells and HPMC Capsules Shell.
With continuous efforts and improvements in policy & adherence to top-notch quality monitoring measures, the Company became the second-largest manufacturer of Empty Hard Gelatin Capsules (EHGC) in India. The Company is WHO-GMP certified Company and has also been recognized as 'Star Export House' by GoI. The Company commenced its manufacturing operation in 1976 with installed capacity of 200 million Hard Gelatin Capsule Shell.
With gradual expansion, it reached to the installed capacity of 10930 million capsules p.a.
The product of the Company Hard Gelatin Capsule Shell is used by Pharmaceutical and Food supplement Companies as a container for administering medicines and food supplements.

FAQs for the comparison of Avience Biomedicals Ltd and Sunil Healthcare Ltd

Which company has a larger market capitalization, Avience Biomedicals Ltd or Sunil Healthcare Ltd?

Market cap of Avience Biomedicals Ltd is 131 Cr while Market cap of Sunil Healthcare Ltd is 71 Cr

What are the key factors driving the stock performance of Avience Biomedicals Ltd and Sunil Healthcare Ltd?

The stock performance of Avience Biomedicals Ltd and Sunil Healthcare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Avience Biomedicals Ltd and Sunil Healthcare Ltd?

As of October 25, 2026, the Avience Biomedicals Ltd stock price is INR ₹240.0. On the other hand, Sunil Healthcare Ltd stock price is INR ₹70.0.

How do dividend payouts of Avience Biomedicals Ltd and Sunil Healthcare Ltd compare?

To compare the dividend payouts of Avience Biomedicals Ltd and Sunil Healthcare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.